A "Man Van" deployed in disadvantaged communities can help identify men at high risk for prostate cancer, according to a ...

The PORTOS assay could indicate when or when not to offer dose-escalated radiation for localized prostate cancer.

Serum testosterone (T) recovery to normal levels is associated with a significant improvement in overall survival in patients ...

Real-world data support trial data on the use of lutetium-177 PSMA-617 in patients with PSMA-positive, metastatic castration-resistant prostate cancer.

Cancer is a life-changing diagnosis, but advancements in medical science have made treatment more effective than ever before.

For years, breast cancer treatment has been guided by genetic alterations found in tumor tissue, typically through invasive biopsies.

Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors (ICIs) durvalumab (Imfinzi) and tremelimumab (Imjudo) had durable responses ...

Radium-223 is an alpha-emitting radiopharmaceutical that accumulates in areas of high bone turnover and has demonstrated a survival benefit in metastatic prostate cancer, 1 but its benefits as a ...

GU ASCO annual meeting featured a prostate cancer session and a presentation by Dr. Benjamin Maughan discussing a prospective trial of a structured exercise program to lessen fatigue in patients with ...

Providence Alaska Medical Center will be the first in the state to offer Pluvicto, an innovative therapy for metastatic ...

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.